SCHEMBL7606978

SCHEMBL7606978

CCCCCNc1nc(CC)c(-c2ccc(OC)cc2OC)nc1OC

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 19/20 0.59
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7476944 0.94 CRHR1 (0.60) CRHR1
SCHEMBL7474786 0.92 CRHR1 (0.63) CRHR1
SCHEMBL7477527 0.89 CRHR1 (0.48) CRHR1
SCHEMBL7479379 0.88 CRHR1 (0.57) CRHR1
SCHEMBL6202370 0.87 CRHR1 (0.51) CRHR1
SCHEMBL5525581 0.83 CRHR1 (0.66) CRHR1
SCHEMBL6201263 0.82 CRHR1 (0.62) CRHR1
SCHEMBL7477918 0.82 CRHR1 (0.70) CRHR1
SCHEMBL7472124 0.82 CRHR1 (0.53) CRHR1
SCHEMBL7480024 0.82 CRHR1 (0.57) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP claimed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO claimed